Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

There are several decision tools to help doctors and patients evaluate the potential benefits of cholesterol medication, and ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...

This inexpensive generic significantly reduced knee pain in a small trial of people who are overweight or have obesity.

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

Advancing diabetes therapy requires an integrative approach that uses emerging technologies. This research topic focuses on the synergy between ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Mounjaro (tirzepatide) is quickly becoming a breakthrough option for people managing type 2 diabetes and those seeking ...